{"name":"Actym Therapeutics, Inc.","slug":"actym-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQLTFtX1VUM0YyZzgwN2Nlb3AzcWdEQnJBSHFHRGNENGlmc2EtcEhxX3Zzd0s3VHQwX0d6NjhxZkJZdThfdUJVcUlnckFnaWJ0cVI0ZGRpdndLcW1EZDhxbzUzZDNFS3hweHhLOXdyVTlpZXVjSVViNmpEcXBHZGp0M19EcTRrVHFnNGZGS3VHRlVabTVvclZudG9KRlZUcmlxT3dHWGpHRlRPSzFsdnJxa2tpWXJUWENwbzl1M0NfcU1scEJSVDF0NGJJYmlPSEJHNVUtY1hfUExoNlF2T2VZanVvX215YWNJNzlQZlBNekZxeHVMZHFJejd0aDNWZ3ROSFpibTVLOFpFR0c0eEM2V3N3S1pPQkI0ZGc?oc=5","date":"2024-06-25","type":"pipeline","source":"PR Newswire","summary":"Actym Therapeutics Expands Management Team with Key Appointments to Build Product Pipeline and Advance Clinical Development Strategies - PR Newswire","headline":"Actym Therapeutics Expands Management Team with Key Appointments to Build Product Pipeline and Advance Clinical Developm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOMy1MVS02MldwTzNNYTluYVNXTzVOU1owaHFTVm9qS19uVnc5bm13R1RjXzdnLUNzWHVyREdmTTZXdUVzel8wNjlEd0JNbzVVcFVsSFhOcGdka2c3Z1FfWnFMWGdMV3ZvWTlhWERRbk5FVS1WYjhYZDdIQ1JjRV9QdXVmTXItZ1lVMlZDbHZYT25nSy14bkh3d0pnaFY2VEd4OG1pdEdMcFBfczA?oc=5","date":"2024-05-30","type":"regulatory","source":"Targeted Oncology","summary":"FDA Greenlights First-in-Human Trial of ACTM-838 for Advanced Solid Tumors - Targeted Oncology","headline":"FDA Greenlights First-in-Human Trial of ACTM-838 for Advanced Solid Tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNRmRia2hvUDJzNUpmZVBvbWZ2YzMzUEVOZnMzWEJpM1R5c25HSUF6OWN0MTBta0N3aEFtNmR3bE1Sc1Vma3lFdVFOZWZDa21SMjI0cS1SdjZCcWg4U3l6QWIzTnNCUlB5RDVRd1c3Wk45MFZXLUhZUVRpM2Ffd3hIMmZlUGJENzZUdmxWRkdUeTE3Y29OSnVRd1Q1QlVvR21tNVVYenBn?oc=5","date":"2024-04-24","type":"pipeline","source":"PR Newswire","summary":"Actym Therapeutics Appoints Thomas Smart as CEO - PR Newswire","headline":"Actym Therapeutics Appoints Thomas Smart as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNVnE1Q0VZN0Y5X19qMVV4VVRQbVRtYURpaGhkTkZWOHMxSHlCWWhwTFM5OU50WEVYXy1lQ3h1MDNVMTZJUHp3LUZRMjYzMF9DdWpNejc0ejJJek5uX0ZlZF9sOG9TNk9LTjFMSjdXaGdFdmRSTno1R1FXUkI5Qm54YTM4NFo1eHN1VFpjNkc4eWZVam9RdVRRa0xZOWpaQUh5NXBKaG0tN1p2N3hiZkgxN1BvTkQ?oc=5","date":"2024-01-05","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Biotech investment diversifies into cell therapies and immunology - drugdiscoverytrends.com","headline":"Biotech investment diversifies into cell therapies and immunology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9QcVQ1LTRSVHRiejJJWFJ1NFJhQXBFR28tYUlCczB5NG91NEl2RUt3blB5YWtHX3RjVmc1NE1BNE90ZGRyRGlDWU9iTG9LUVZYSF9wQUNvbDVDWFpaczRJ?oc=5","date":"2023-12-11","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNX0ZucFdRVEl2MU9PNzlCSGF2MkMtQk1JT1dxdmhQWnBvN3M0TVR0dHk0OTMyMlI4bFZCZC1pa0dJd2szVzNNdS03WHRCZnBzcXdGdHBTYTBqUnVFZUNfQzg3OEc5MDhsTmZrcWtvZUFfaTZqNmFSZDVzZ1Bzc2RqMnF3bkxWNHN5cllGS2JtdXlaWGpfS3FpVXpIbFc?oc=5","date":"2022-05-12","type":"pipeline","source":"BioSpace","summary":"Actym Therapeutics Announces Significant Expansion of Senior Leadership - BioSpace","headline":"Actym Therapeutics Announces Significant Expansion of Senior Leadership","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}